Microbot Medical MBOT 深 沪
等待开盘 08-19 09:30:00 美东时间
1.4711
-0.039
-2.58%
华盛通- 最 高1.51
- 今 开1.49
- 成交量 102.84万股
- 最 低 1.44
- 昨 收 1.51
- 总市值 9880.61万
- 52周最高 4.67
- 市盈率 静 --
- 换手率 1.53%
- 52周最低 1.44
- 委 比 12.58%
- 总股本 6716.48万
- 历史最高 149.10
- 量 比 1.43
- 振 幅 4.64%
- 历史最低 0.82
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Microbot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.
Microbot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.
08-11 23:17
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $241.000 thousand which missed the analyst co...
08-11 21:24
Microbot Medical Showcased at Society of Robotic Surgery
Microbot Medical ( ($MBOT) ) has provided an update. On July 21, 2026, Microbot...
07-21 20:59
Microbot Medical accelerates LIBERTY growth and expansion
Microbot Medical ( ($MBOT) ) just unveiled an update. In the second quarter of ...
07-07 20:59
Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter ended June 30, 2026, compared to the first quarter ended March 31, 2026.
07-07 20:35
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal healthcare systems, such as those administered by the Veterans Health Administration (VHA), a divisi...
06-16 20:38
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.
06-04 01:51
Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has achieved a significant regulatory milestone as Israel becomes the second
05-26 20:32
